Results 1 to 10 of about 41,455 (247)

INVASIVE PNEUMOCOCCAL DISEASES IN CHILDREN AGED 1-59 MONTHS IN SICILY, ITALY: IMPORTANCE OF ACTIVE FAMILY PAEDIATRICIAN SURVEILLANCE AND VACCINATION COVERAGE. [PDF]

Euromediterranean Biomedical Journal, 2014
Purpose: Aim of this study was to analyze pediatric invasive pneumococcal disease rates several years after the implementation of infant pneumococcal vaccination. Methods: The study was carried out in Sicily and involved about 30,000 children, aged 1-
Emanuele Amodio
doaj   +4 more sources

Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales. [PDF]

PLoS ONE, 2012
England and Wales recently replaced the 7-valent pneumococcal conjugate vaccine (PCV7) with its 13-valent equivalent (PCV13), partly based on projections from mathematical models of the long-term impact of such a switch compared to ceasing pneumococcal ...
Yoon Hong Choi, Mark Jit, Stefan Flasche, Nigel Gay, Elizabeth Miller   +4 more
doaj   +5 more sources

Invasive pneumococcal disease presenting with abdominal pain, vomiting and diarrhoea in a patient with multiple myeloma [PDF]

European Journal of Case Reports in Internal Medicine
Background: Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and meningitis, but intra-abdominal manifestations are rare, particularly in adults without underlying peritoneal disease.
Hélder Diogo Gonçalves, Ana Melício, Mariana Dias, Sara Vasconcelos-Teixeira, Inês Quinteiro, Ana Luísa Barbosa, João Madeira Lopes   +6 more
doaj   +2 more sources

Minimum incidence of adult invasive pneumococcal disease in Blantyre, Malawi an urban african setting: a hospital based prospective cohort study. [PDF]

PLoS ONE, 2015
Invasive pneumococcal disease causes substantial morbidity and mortality in Africa. Evaluating population level indirect impact on adult disease of pneumococcal conjugate vaccine (PCV) programmes in infants requires baseline population incidence rates ...
Naor Bar-Zeev, Neema Mtunthama, Stephen B Gordon, Gershom Mwafulirwa, Neil French   +4 more
doaj   +5 more sources

Outbreak of Serotype 1 Invasive Pneumococcal Disease, Kibera Urban Informal Settlement, Nairobi, Kenya, 2023 [PDF]

Emerging Infectious Diseases
Use of 10-valent pneumococcal conjugate vaccine in Kenya has led to substantial reductions in vaccine-type pneumococcal carriage and invasive pneumococcal disease.
Terry Komo, Patrick K. Munywoki, Maria da Gloria Carvalho, Joshua Auko, Alice Ouma, Allan Audi, George O. Agogo, Daniel Omondi, Arthur Odoyo, Herine Odiembo, Newton Wamola, Mike Osita, Clayton Onyango, Naomi Lucchi, Peninah Munyua, Amy Herman-Roloff, Shanda Larson, Sopio Chochua, Fabiana C. Pimenta, Godfrey Bigogo, Jennifer R. Verani   +20 more
doaj   +2 more sources

Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]

, 2014
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
A Fenoll, A Kacou-N'Douba, A Kacou-N'douba, A Roca, A von Gottberg, A Woolfson, A Yomo, AB Brueggemann, AH Skalet, AK Rowe, Andrew Hall, B Frederiksen, B Oppenheim, BM Gray, BM Gray, C Levy, Caroline L. Trotter, Christian Bottomley, CL Trotter, D Bogaert, D Hansman, DB Blossom, DM Denno, DM Mwenya, DR Feikin, DR Feikin, E Varon, Effua Usuf, ES Donkor, EV Millar, G Regev-Yochay, GA Mackenzie, H Faden, H Rinta-Kokko, H Smith-Vaughan, HL Johnson, HT Vu, ID Rusen, JA Scott, JAG Scott, JD Kellner, JR Scott, KA Robinson, KL O'Brien, KL O'Brien, KP Klugman, L Marcus, L Pemba, LC Bere, LM McNally, M Antonio, M Guevara, M Mthwalo, MF Cotton, MK Darboe, MK Darboe, ML Joloba, MO Ota, MR Capeding, MR Jacobs, MW Mureithi, N Lloyd-Evans, N Mbelle, NOA Nwachukwu, O Abdullahi, O Abdullahi, PC Hill, PC Hill, PC Hill, PL Ho, PW Roche, R Dagan, RA Adegbola, RE Huebner, RE Huebner, Richard A. Adegbola, RK Syrjanen, RM Robins-Browne, RN Ndip, S Haug, S Yang, SB Gordon, SK Obaro, SK Obaro, SL Batt, SL Kaplan, SR Williams, SS Huang, WM Nyandiko, X Valles, YB Cheung, YT Kandakai-Olukemi   +91 more
core   +29 more sources

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis [PDF]

Frontiers in Medicine
BackgroundStreptococcus pneumoniae and its infections are a global public health concern. Invasive pneumococcal disease accounts for significant mortality in the aged and immunocompromised. Over 100 unique capsular serotypes have been identified, with 80–
Samuel Darkwah, Namwin S. Somda, Samiratu Mahazu, Eric S. Donkor   +3 more
doaj   +2 more sources

A Retrospective Analysis to Estimate the Burden of Invasive Pneumococcal Disease and Non-Invasive Pneumonia in Children <15 Years of Age in the Veneto Region, Italy

Children, 2022
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause significant morbidity and mortality in children. We studied the annual incidence of pneumococcal-specific and syndromic invasive disease and non-invasive ...
Elisa Barbieri, Gloria Porcu, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti, Carlo Giaquinto   +9 more
doaj   +1 more source

Invasive pneumococcal disease [PDF]

Archives of disease in childhood - Education & practice edition, 2011
Streptococcus pneumoniae , the pneumococcus, is a Gram-positive diplococcus with more than 90 serotypes determined by the polysaccharide composition of its capsule. It is carried asymptomatically in approximately 50% of people.1 It can cause both non-invasive and invasive disease.
Elise, Randle, Nelly, Ninis, David, Inwald   +2 more
openaire   +2 more sources

Cardiotoxicity during Invasive Pneumococcal Disease [PDF]

American Journal of Respiratory and Critical Care Medicine, 2015
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and sepsis, with adult hospitalization linked to approximately 19% incidence of an adverse cardiac event (e.g., heart failure, arrhythmia, infarction). Herein, we review the specific host-pathogen interactions that contribute to cardiac dysfunction during invasive ...
Brown, AO, Millett, ERC, Quint, JK, Orihuela, CJ   +3 more
openaire   +4 more sources